학술논문
Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket study
Document Type
Article
Author
Source
In Lung Cancer June 2023 180
Subject
Language
ISSN
0169-5002